Hyoe Inomata

825 total citations
11 papers, 625 citations indexed

About

Hyoe Inomata is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Hyoe Inomata has authored 11 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Oncology. Recurrent topics in Hyoe Inomata's work include BRCA gene mutations in cancer (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Hyoe Inomata is often cited by papers focused on BRCA gene mutations in cancer (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Hyoe Inomata collaborates with scholars based in Japan and United States. Hyoe Inomata's co-authors include Yasushi Kobayashi, Fujío Numano, Ronald McKinney, Tohru Fukai, Masuko Ushio‐Fukai, Norifumi Urao, Masooma Razvi, Ha Won Kim, Kishore K. Wary and Kalyankar Mahadev and has published in prestigious journals such as The Lancet, Circulation Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Hyoe Inomata

11 papers receiving 612 citations

Peers

Hyoe Inomata
Comparison fields: 5 of 72
  • Molecular Biology 285
  • Pulmonary and Respiratory Medicine 187
  • Immunology 153
  • Surgery 96
  • Physiology 95
Replace Erika Folestad with:
Erika Folestad Sweden
Tan Pham United States
Anna Guadall Spain
Mar Orriols Spain
Frauke May Germany
Ling Hou China
Lisa S. Ang Canada
Jens Eichhorn Germany
Tong Huan Jin China
Piere Rogalla Germany
Erika Folestad Sweden View profile →
Citations per field, relative to Hyoe Inomata
Hyoe Inomata · 1×
Citations per year, relative to Hyoe Inomata
Hyoe Inomata · 1×

Countries citing papers authored by Hyoe Inomata

Since Specialization
Citations

This map shows the geographic impact of Hyoe Inomata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyoe Inomata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyoe Inomata more than expected).

Fields of papers citing papers by Hyoe Inomata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyoe Inomata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyoe Inomata. The network helps show where Hyoe Inomata may publish in the future.

Co-authorship network of co-authors of Hyoe Inomata

This figure shows the co-authorship network connecting the top 25 collaborators of Hyoe Inomata. A scholar is included among the top collaborators of Hyoe Inomata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyoe Inomata. Hyoe Inomata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Work Indexed citations
1 11
2 6
3 35
4 151
5 152
6 14
7 4
8 11
9 36
10 191
11 14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026